Showing 1 - 8 results of 8 for search 'Anna Maria Geretti', query time: 0.03s Refine Results
  1. 1
    The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance

    The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance by Drieda Zaçe, Albiana Çekrezi, Christopher Jones, Ludovica Ferrari, Giuseppe De Simone, Elisabetta Teti, Vincenzo Malagnino, Marco Iannetta, Loredana Sarmati, Anna Maria Geretti

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysis

    Evolution of the burden of active hepatitis C virus infection in England from September 2015 to September 2016: a repeated cross-sectional analysis by Jason Gordon, Anna Maria Geretti, Lynsey Corless, Laure Lacoin, Michael Hurst, Nathan R Hill, Richard Aspinall, Yuxiang Gao-Du, Liam Mistry, David Mutimer

    Published 2019-08-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucleos(t)ide analogue resistance– a phase IV randomised, open-label study (PIBIK study)

    Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in virologically suppressed adults with nucl... by Collins Iwuji, Laura Waters, Ana Milinkovic, Chloe Orkin, Julie Fox, Frank Post, Nicky Perry, Chloe Bruce, Natalie Dailey, Ye To, Stephen Bremner, Duncan Churchill, Anna Maria Geretti

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D.

    Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D. by Geraldine M Foster, John C Ambrose, Stéphane Hué, Valerie C Delpech, Esther Fearnhill, Ana B Abecasis, Andrew J Leigh Brown, Anna Maria Geretti, UK HIV Drug Resistance Database

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

    Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. by Anna Maria Geretti, Zoe Fox, Jeffrey A Johnson, Clare Booth, Jonathan Lipscomb, Lieven J Stuyver, Gilda Tachedjian, John Baxter, Giota Touloumi, Clara Lehmann, Andrew Owen, Andrew Phillips, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana.

    Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana. by Philippa C Matthews, Apostolos Beloukas, Amna Malik, Jonathan M Carlson, Pieter Jooste, Anthony Ogwu, Roger Shapiro, Lynn Riddell, Fabian Chen, Graz Luzzi, Manjeetha Jaggernath, Gerald Jesuthasan, Katie Jeffery, Thumbi Ndung'u, Philip J R Goulder, Anna Maria Geretti, Paul Klenerman

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.

    Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response. by Jurgen Vercauteren, Gertjan Beheydt, Mattia Prosperi, Pieter Libin, Stijn Imbrechts, Ricardo Camacho, Bonaventura Clotet, Andrea De Luca, Zehava Grossman, Rolf Kaiser, Anders Sönnerborg, Carlo Torti, Eric Van Wijngaerden, Jean-Claude Schmit, Maurizio Zazzi, Anna-Maria Geretti, Anne-Mieke Vandamme, Kristel Van Laethem

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics.

    The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics. by Andrew Speakman, Alison Rodger, Andrew N Phillips, Richard Gilson, Margaret Johnson, Martin Fisher, Ed Wilkins, Jane Anderson, Rebecca O'Connell, Monica Lascar, Kazeem Aderogba, Simon Edwards, Jeffrey McDonnell, Nicky Perry, Lorraine Sherr, Simon Collins, Graham Hart, Anne M Johnson, Alec Miners, Jonathan Elford, Anna-Maria Geretti, William J Burman, Fiona C Lampe

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: